Psychopathy is a key to integrating dimensional personality disorder constructs and psychotherapy: toward a reformulation of personality and its disruption
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
For the popular diabetes and obesity medications known as GLP-1s, addiction medicine is one of many possible promising next acts.
Eli Lilly is investigating a new drug, brenipatide, and testing it in alcohol use disorder. A new company called Baseline Therapeutics is studying a GLP-1 receptor agonist in alcohol, cocaine, and methamphetamine use disorders; Altimmune is testing one called pemvidutide for alcohol. Addiction medicine specialists are hopeful that the Food and Drug Administration may soon approve a new medication for alcohol use disorder — the first in two decades.
But some telehealth platforms that specialize in treating addiction aren’t waiting. In the last year, a few companies have begun to market off-label prescriptions of GLP-1s, both branded and compounded, to treat alcohol use disorder and other addictions.
Evaluating the PolarUs App in People With Bipolar Disorder
Interventions: Device: PolarUs Mobile App
Sponsors: University of British Columbia; Canadian Institutes of Health Research (CIHR)
Not yet recruiting
Assisting Screening of Adolescent Depression With Large Language Models as Symptom Detectors: Algorithm Development and Validation
An Education and Support Chatbot for Postpartum Mothers With Opioid Use Disorder: Qualitative Needs Assessment
Background: The prevalence of opioid use disorder (OUD) among women giving birth in US hospitals continues to rise. Increasing fatalities due to perinatal drug overdose have in part been attributed to decreased access to social support and treatment services. In recent years, mobile health (mHealth) technologies have been used to provide care to patients outside of traditional clinical settings. Given that perinatal OUD treatment works best when there is frequent contact between patient and clinician, harnessing mHealth could be valuable for improving patient engagement in perinatal OUD care. Objective: To address the increasing epidemic of perinatal OUD, which is compounded by loneliness and social isolation, this study aimed to adapt an existing mHealth chatbot intervention for postpartum individuals by developing educational and supportive content relevant to people in the postpartum period experiencing OUD and recovery. Methods: We used a participatory design to conduct a needs assessment via in-depth qualitative interviews with patients (n=12) and providers (n=11). Interview data were analyzed using NVivo software (Lumivero) according to a priori codebooks and using inductive coding, which identified major themes to address in a future adaptation of an interactive chatbot. An advisory board was convened to review the data and contribute to content generation that would be most useful for perinatal mothers who are in treatment for OUD. Results: Patients and providers agreed that an interactive chatbot would be useful for patients seeking information on childbirth recovery, substance use recovery, pain management, and infant care, including feeding. Patients specifically wanted a chatbot that felt personal and addressed their individual and specific needs. Providers indicated that the chatbot should address topics that came up frequently in after-hours phone calls to reduce provider burden. Conclusions: Conducting an in-depth participatory-driven needs assessment will support the refinement of an existing chatbot to better meet the needs of a high-risk, difficult-to-reach population. As we move forward to test the chatbot for acceptability and feasibility, data from the needs assessment will support ongoing iterative enhancement of the content, delivery, and safety of the chatbot.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/4711641658d6f7798d35a50de0518027" />
Depressive symptoms and occupational correlates among psychiatric nurses in northern Jiangsu: an explanatory sequential mixed-methods study
Psychiatric service dogs reduce loneliness and improve social functioning in adults with mental health conditions: a qualitative study from South Africa
Beyond diagnostic categories: transdiagnostic psychological mechanisms associated with suicidal ideation among university students: a systematic review (2021–2025)
Simultaneous measurement of Midbrain and Striatal Dopamine in Schizophrenia using an agonist radiotracer
Imaging studies showing greater amphetamine-induced dopamine release in patients with schizophrenia (SCZ) compared to matched healthy controls (HC) have been repeatedly replicated, but these studies all used radiotracers that were dopamine D2 receptor antagonists. A more recent study using an agonist radiotracer did not detect this increase, raising a question whether the difference in radiotracer pharmacology affected the result. Another study examining the extrastriatal response to the amphetamine challenge with an antagonist tracer observed a blunted effect in SCZ in the midbrain, suggesting mechanisms local to the striatum might have contributed to the striatal imaging results independent of midbrain dopamine availability.

